Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pediatric
81%
Seizure
52%
N-methyl-D-aspartate Receptor (NMDAR)
45%
Encephalitis
43%
Autoimmune Encephalitis
43%
Autoantibodies
40%
Acquired Demyelinating Syndromes
34%
Epilepsy
32%
Epileptic Encephalopathy
30%
LGI1
29%
Antibody-mediated
28%
Acute Disseminated Encephalomyelitis
28%
MOG-Ab
26%
Clinical Features
24%
N-methyl-D-aspartate Receptor Antibody
23%
Aquaporin-4 (AQP4)
22%
Onconeural Antibodies
22%
Autoimmune
22%
Magnetoencephalography
22%
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
22%
CASPR2
20%
Pediatric Autoimmune Encephalitis
19%
Multiple Sclerosis
18%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
17%
Disease Course
17%
Pediatric multiple Sclerosis
16%
Rodent Models
16%
Myelin Oligodendrocyte Glycoprotein Antibody
15%
VGKC-complex
14%
Brain Networks
14%
Epileptic Seizure
13%
Myelin Oligodendrocyte Glycoprotein
13%
Central Nervous System
13%
Surveillance Studies
12%
Acquired Demyelinating Disease
12%
Disease-modifying Therapy
12%
Patient-derived
12%
Encephalopathy
12%
Early Treatment
11%
Paraclinical
11%
AMPA Receptor (AMPAR)
11%
Demyelinating Diseases
10%
Optic Neuritis
10%
Pediatric Epilepsy
10%
Epileptiform Activity
10%
VGKC Antibody
9%
Antibody-negative
9%
Mouse Model
9%
Passive Transfer
9%
Autoimmune Epilepsy
9%
Neuroscience
Encephalitis
76%
Brain Disease
45%
Autoantibodies
42%
Myelin Oligodendrocyte Glycoprotein
39%
Immunotherapy
37%
Receptor Antibody
30%
Aspartic Acid
30%
In Vivo
28%
Receptor
28%
Multiple Sclerosis
26%
Leucine
25%
Contactin
25%
Magnetoencephalography
22%
Acute Disseminated Encephalomyelitis
21%
Magnetic Resonance Imaging
21%
In Vitro
21%
Central Nervous System
18%
Demyelinating Disease
17%
Nervous System Disorder
17%
Brain Network
16%
Dextro Aspartic Acid
15%
Magnetic Resonance Imaging of Brain
14%
Behavior (Neuroscience)
12%
Optic Neuritis
11%
AMPA Receptor
11%
Status Epilepticus
10%
Pediatric Epilepsy
10%
Limbic Encephalitis
10%
Neuromyelitis Optica
10%
Synaptic Transmission
9%
Axonin 1
9%
Voltage-Gated Potassium Channel
9%
Aquaporin 4 Antibody
9%
Expanded Disability Status Scale
9%
Ictal
9%
Neurosteroid
8%
Relapsing Remitting Multiple Sclerosis
8%
Stereotypic Movement Disorder
8%
Neurophysiology
8%
Cognitive Disorders
7%
Epileptic Seizure
7%
Immune System Disorders
7%
Focal Epilepsy
7%
Intravenous Immunoglobulin
6%
Immunoglobulin G
6%
Electrophysiology
6%
Nerve Fiber
6%
Synapsin I
6%
Receptor Protein
6%
Autoantigen
6%
Medicine and Dentistry
Pediatrics
100%
Epileptic Seizure
33%
Brain Disease
33%
Acute Disseminated Encephalomyelitis
28%
Multiple Sclerosis
23%
Diseases
22%
Myelin Oligodendrocyte Glycoprotein
21%
Aquaporin 4 Antibody
21%
Allergic Encephalitis
21%
Magnetic Resonance Imaging
21%
Immunotherapy
19%
Encephalitis
19%
Clinical Feature
17%
Autoantibodies
16%
Autoimmunity
16%
Disease Course
16%
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
14%
Receptor Antibody
14%
Clinically Isolated Syndrome
13%
Magnetoencephalography
12%
MOG Antibody Disease
12%
Combination Therapy
12%
Central Nervous System
11%
Contactin
10%
Neuromyelitis Optica
9%
Dextro Aspartic Acid
9%
N Methyl-D-Aspartate Receptor
9%
Paraneoplastic Cerebellar Degeneration
9%
Ganglioglioma
9%
Leucine
9%
Partial Seizure
8%
Pediatric Neurology
8%
Transverse Myelitis
8%
Voltage-Gated Potassium Channel
8%
Magnetic Resonance Imaging of Brain
8%
AMPA Receptor
7%
Recurrent Disease
7%
Onset Age
7%
Maintenance Therapy
6%
Neurologic Disease
6%
School-Age Children
6%
Treatment Response
6%
Brain Tissue
6%
Autoantigen
6%
Endocrine Disease
6%
Epileptiform Activity
6%
Psychological Outcome
6%
Basal Ganglia
6%
Disease Modifying Therapy
6%
Sudden Unexpected Death in Epilepsy
6%